Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2011 3
2012 1
2013 1
2014 2
2015 2
2016 6
2017 4
2018 2
2019 9
2020 7
2021 9
2022 8
2023 8
2024 5
2025 4
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.
Ghaneh P, Palmer D, Cicconi S, Jackson R, Halloran CM, Rawcliffe C, Sripadam R, Mukherjee S, Soonawalla Z, Wadsley J, Al-Mukhtar A, Dickson E, Graham J, Jiao L, Wasan HS, Tait IS, Prachalias A, Ross P, Valle JW, O'Reilly DA, Al-Sarireh B, Gwynne S, Ahmed I, Connolly K, Yim KL, Cunningham D, Armstrong T, Archer C, Roberts K, Ma YT, Springfeld C, Tjaden C, Hackert T, Büchler MW, Neoptolemos JP; European Study Group for Pancreatic Cancer. Ghaneh P, et al. Among authors: tjaden c. Lancet Gastroenterol Hepatol. 2023 Feb;8(2):157-168. doi: 10.1016/S2468-1253(22)00348-X. Epub 2022 Dec 12. Lancet Gastroenterol Hepatol. 2023. PMID: 36521500 Free article. Clinical Trial.
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial.
Palmer DH, Jackson R, Springfeld C, Ghaneh P, Rawcliffe C, Halloran CM, Faluyi O, Cunningham D, Wadsley J, Darby S, Meyer T, Gillmore R, Lind P, Glimelius B, Falk S, Ma YT, Middleton GW, Cummins S, Ross PJ, Wasan H, McDonald A, Crosby T, Hammel P, Borg D, Sothi S, Valle JW, Mehrabi A, Bailey P, Tjaden C, Michalski C, Hackert T, Büchler MW, Neoptolemos JP. Palmer DH, et al. Among authors: tjaden c. J Clin Oncol. 2025 Apr;43(10):1240-1253. doi: 10.1200/JCO.24.01118. Epub 2024 Dec 5. J Clin Oncol. 2025. PMID: 39637340 Free PMC article. Clinical Trial.
[Pancreas divisum and pancreatitis].
Khristenko E, Tjaden C, Klauß M. Khristenko E, et al. Among authors: tjaden c. Radiologe. 2021 Jun;61(6):541-547. doi: 10.1007/s00117-021-00848-w. Epub 2021 May 3. Radiologe. 2021. PMID: 33942124 Review. German.
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC.
Zhou X, An J, Kurilov R, Brors B, Hu K, Peccerella T, Roessler S, Pfütze K, Schulz A, Wolf S, Hohmann N, Theile D, Sauter M, Burhenne J, Ei S, Heger U, Strobel O, Barry ST, Springfeld C, Tjaden C, Bergmann F, Büchler M, Hackert T, Fortunato F, Neoptolemos JP, Bailey P. Zhou X, et al. Among authors: tjaden c. Nat Cancer. 2023 Sep;4(9):1362-1381. doi: 10.1038/s43018-023-00628-6. Epub 2023 Sep 7. Nat Cancer. 2023. PMID: 37679568 Free PMC article.
Central pancreatectomy prevents postoperative diabetes.
Klotz R, Schilling C, Kuner C, Hinz U, Klaiber U, Holze M, Tjaden C, Loos M, Büchler MW, Hackert T. Klotz R, et al. Among authors: tjaden c. J Hepatobiliary Pancreat Sci. 2023 Jul;30(7):951-961. doi: 10.1002/jhbp.1296. Epub 2022 Dec 13. J Hepatobiliary Pancreat Sci. 2023. PMID: 36457298
Neoadjuvant and adjuvant chemotherapy in pancreatic cancer.
Klaiber U, Leonhardt CS, Strobel O, Tjaden C, Hackert T, Neoptolemos JP. Klaiber U, et al. Among authors: tjaden c. Langenbecks Arch Surg. 2018 Dec;403(8):917-932. doi: 10.1007/s00423-018-1724-8. Epub 2018 Nov 5. Langenbecks Arch Surg. 2018. PMID: 30397779 Review.
Symptomatic marginal ulcer after pancreatoduodenectomy.
Sulieman I, Strobel O, Scharenberg C, Mihaljevic AM, Müller BM, Diener MK, Mehrabi A, Schneider M, Berchtold C, Tjaden C, Hinz U, Feisst M, Büchler MW, Hackert T, Loos M. Sulieman I, et al. Among authors: tjaden c. Surgery. 2020 Jul;168(1):67-71. doi: 10.1016/j.surg.2020.02.012. Epub 2020 Apr 7. Surgery. 2020. PMID: 32276736
Radical surgery of oligometastatic pancreatic cancer.
Hackert T, Niesen W, Hinz U, Tjaden C, Strobel O, Ulrich A, Michalski CW, Büchler MW. Hackert T, et al. Among authors: tjaden c. Eur J Surg Oncol. 2017 Feb;43(2):358-363. doi: 10.1016/j.ejso.2016.10.023. Epub 2016 Nov 9. Eur J Surg Oncol. 2017. PMID: 27856064
60 results